Anjali Shah

Anjali Shah is an experienced professional in the pharmaceutical industry, currently serving as Executive Director of Business Capabilities & Excellence and Chief of Staff for Worldwide Patient Safety at Bristol Myers Squibb since November 2019. Shah has held several senior leadership roles including Executive Director of Business Capabilities and Innovation and Sr. Director of Business Capabilities and Innovation at Bristol Myers Squibb. Prior experience includes Sr. Director of Safety Operations Strategy and Planning at Celgene and various roles focused on medical content and information at both Celgene and Bristol-Myers Squibb. Earlier career highlights include a position as a Medical Science Liaison at Allergan and multiple managerial roles at Bristol-Myers Squibb. Anjali Shah holds a degree from Rutgers University, attended from 1998 to 2004.